TBF1.F - Canntab Therapeutics Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue2018-05-312017-05-31
Total Revenue26.667-
Cost of Revenue--
Gross Profit26.667-
Operating Expenses
Research Development140.73240.685
Selling General and Administrative1,195.338392.665
Non Recurring--
Others--
Total Operating Expenses1,707.491,116.565
Operating Income or Loss-1,680.823-1,116.565
Income from Continuing Operations
Total Other Income/Expenses Net-727.590.313
Earnings Before Interest and Taxes-1,680.823-1,116.565
Interest Expense--
Income Before Tax-2,408.413-1,116.252
Income Tax Expense--
Minority Interest--
Net Income From Continuing Ops-2,408.413-1,116.252
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-2,408.413-1,116.252
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-2,408.413-1,116.252